APA (7th ed.) Citation

Rosenberg, J. E., Hoffman-Censits, J., Powles, T., van der Heijden, M. S., Balar, A. V., Necchi, A., . . . Castellano, D. (2016). Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial. Lancet, 387(10031), 1909. https://doi.org/10.1016/S0140-6736(16)00561-4

Chicago Style (17th ed.) Citation

Rosenberg, Jonathan E., et al. "Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma Who Have Progressed Following Treatment with Platinum-based Chemotherapy: A Single-arm, Multicentre, Phase 2 Trial." Lancet 387, no. 10031 (2016): 1909. https://doi.org/10.1016/S0140-6736(16)00561-4.

MLA (9th ed.) Citation

Rosenberg, Jonathan E., et al. "Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma Who Have Progressed Following Treatment with Platinum-based Chemotherapy: A Single-arm, Multicentre, Phase 2 Trial." Lancet, vol. 387, no. 10031, 2016, p. 1909, https://doi.org/10.1016/S0140-6736(16)00561-4.